Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Long-Term Investments (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Long-Term Investments for 5 consecutive years, with $64.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Investments changed N/A year-over-year to $64.9 million, compared with a TTM value of $64.9 million through Sep 2025, changed N/A, and an annual FY2024 reading of $74.5 million, changed N/A over the prior year.
  • Long-Term Investments was $64.9 million for Q3 2025 at Tandem Diabetes Care, down from $67.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $74.5 million in Q4 2024 and bottomed at $64.9 million in Q3 2025.